Raymond J. Henley Iii

Array ( [id] => 4311496 [patent_doc_number] => 06316404 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-11-13 [patent_title] => 'Treating NIDDM with RXR agonists' [patent_app_type] => 1 [patent_app_number] => 9/745681 [patent_app_country] => US [patent_app_date] => 2000-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 8109 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/316/06316404.pdf [firstpage_image] =>[orig_patent_app_number] => 745681 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1570483 [patent_doc_number] => 06498152 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-12-24 [patent_title] => 'Use of a farnesyl transferase inhibitor in the manufacture of a medicament for local administration to the vascular wall in the prevention of restenosis' [patent_app_type] => B1 [patent_app_number] => 09/674584 [patent_app_country] => US [patent_app_date] => 2000-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 3332 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/498/06498152.pdf [firstpage_image] =>[orig_patent_app_number] => 09674584 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4363541 [patent_doc_number] => 06287599 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles' [patent_app_type] => 1 [patent_app_number] => 9/741548 [patent_app_country] => US [patent_app_date] => 2000-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3301 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/287/06287599.pdf [firstpage_image] =>[orig_patent_app_number] => 741548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105503 [patent_doc_number] => 20010004643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-06-21 [patent_title] => 'Pharmaceutical composition with sotalol combination and their use in treatment of cardiac ailments' [patent_app_type] => new-utility [patent_app_number] => 09/739276 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5001 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20010004643.pdf [firstpage_image] =>[orig_patent_app_number] => 09739276 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4320216 [patent_doc_number] => 06248731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-19 [patent_title] => 'Stabilized aspirin compositions and method of preparation for oral & topical use' [patent_app_type] => 1 [patent_app_number] => 9/739018 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2332 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/248/06248731.pdf [firstpage_image] =>[orig_patent_app_number] => 739018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7964169 [patent_doc_number] => 06680343 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-20 [patent_title] => 'Treatment of renal colic with GABA analogs' [patent_app_type] => B1 [patent_app_number] => 09/720007 [patent_app_country] => US [patent_app_date] => 2000-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2044 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/680/06680343.pdf [firstpage_image] =>[orig_patent_app_number] => 09720007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4261739 [patent_doc_number] => 06306392 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-23 [patent_title] => 'Composition comprising a carnitine and glutathione, useful to increase the absorption of glutathione and synergize its effects' [patent_app_type] => 1 [patent_app_number] => 9/719176 [patent_app_country] => US [patent_app_date] => 2000-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5729 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/306/06306392.pdf [firstpage_image] =>[orig_patent_app_number] => 719176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636411 [patent_doc_number] => 06380248 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-30 [patent_title] => 'Metal-thiols as immunomodulating agents' [patent_app_type] => B1 [patent_app_number] => 09/601491 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 10 [patent_no_of_words] => 6552 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/380/06380248.pdf [firstpage_image] =>[orig_patent_app_number] => 09601491 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7636940 [patent_doc_number] => 06379715 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-04-30 [patent_title] => 'Method for treatment of psoriasis' [patent_app_type] => B2 [patent_app_number] => 09/737258 [patent_app_country] => US [patent_app_date] => 2000-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2881 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/379/06379715.pdf [firstpage_image] =>[orig_patent_app_number] => 09737258 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383138 [patent_doc_number] => 06277834 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Agents for relieving side effects of adrenal cortex hormone' [patent_app_type] => 1 [patent_app_number] => 9/719384 [patent_app_country] => US [patent_app_date] => 2000-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2683 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277834.pdf [firstpage_image] =>[orig_patent_app_number] => 719384 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4409999 [patent_doc_number] => 06300343 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Method of treatment' [patent_app_type] => 1 [patent_app_number] => 9/719378 [patent_app_country] => US [patent_app_date] => 2000-12-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3080 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300343.pdf [firstpage_image] =>[orig_patent_app_number] => 719378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6948057 [patent_doc_number] => 20010021693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'FORMULATION OF VALNEMULIN' [patent_app_type] => new [patent_app_number] => 09/733477 [patent_app_country] => US [patent_app_date] => 2000-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2122 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021693.pdf [firstpage_image] =>[orig_patent_app_number] => 09733477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1477892 [patent_doc_number] => 06344444 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-02-05 [patent_title] => 'Arginine-silicate-inositol complex and use thereof' [patent_app_type] => B1 [patent_app_number] => 09/730895 [patent_app_country] => US [patent_app_date] => 2000-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3796 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/344/06344444.pdf [firstpage_image] =>[orig_patent_app_number] => 09730895 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7001087 [patent_doc_number] => 20010053790 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-20 [patent_title] => 'Mothod and composition for treatment of ischemic neuronal reperfusion injury' [patent_app_type] => new [patent_app_number] => 09/727707 [patent_app_country] => US [patent_app_date] => 2000-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4169 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20010053790.pdf [firstpage_image] =>[orig_patent_app_number] => 09727707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1193234 [patent_doc_number] => 06730685 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-04 [patent_title] => 'Formulation of substituted benzimidazoles' [patent_app_type] => B1 [patent_app_number] => 09/701714 [patent_app_country] => US [patent_app_date] => 2000-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3005 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730685.pdf [firstpage_image] =>[orig_patent_app_number] => 09701714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7065582 [patent_doc_number] => 20010044447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-22 [patent_title] => 'Method for the prevention or treatment of a motoneuron disease' [patent_app_type] => new [patent_app_number] => 09/727131 [patent_app_country] => US [patent_app_date] => 2000-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2158 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20010044447.pdf [firstpage_image] =>[orig_patent_app_number] => 09727131 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4383946 [patent_doc_number] => 06277883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-21 [patent_title] => 'Method of treating male impotence by enhancing the effectiveness of the human immune system' [patent_app_type] => 1 [patent_app_number] => 9/717634 [patent_app_country] => US [patent_app_date] => 2000-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1050 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/277/06277883.pdf [firstpage_image] =>[orig_patent_app_number] => 717634 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7640196 [patent_doc_number] => 06395719 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-05-28 [patent_title] => 'Methods for increasing levels of acetylcholine' [patent_app_type] => B1 [patent_app_number] => 09/700506 [patent_app_country] => US [patent_app_date] => 2000-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3450 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/395/06395719.pdf [firstpage_image] =>[orig_patent_app_number] => 09700506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446892 [patent_doc_number] => 06369065 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'CD40 signal blocking agent' [patent_app_type] => B1 [patent_app_number] => 09/711620 [patent_app_country] => US [patent_app_date] => 2000-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7524 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/369/06369065.pdf [firstpage_image] =>[orig_patent_app_number] => 09711620 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4323334 [patent_doc_number] => 06331557 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-18 [patent_title] => 'Use of divalent cations for inhibiting erythrocyte dehydration in vivo' [patent_app_type] => 1 [patent_app_number] => 9/530710 [patent_app_country] => US [patent_app_date] => 2000-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 7 [patent_no_of_words] => 7275 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/331/06331557.pdf [firstpage_image] =>[orig_patent_app_number] => 530710 [rel_patent_id] =>[rel_patent_doc_number] =>)